Cervical dystonia receiving treatment with botulinum toxin type. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Neck Muscles Globus Pallidus Upper Extremity Cervical Vertebrae Sweat Glands Basal Ganglia Facial Muscles Neuromuscular Junction Oculomotor Muscles

Organisms4

Clostridium botulinum Clostridium botulinum type A Clostridium botulinum type E Clostridium botulinum type B

Diseases30

Torticollis Dystonia Muscle Spasticity Dystonic Disorders Botulism Blepharospasm Hyperhidrosis Sialorrhea Paraparesis, Spastic Hemifacial Spasm Dystonia Musculorum Deformans Hypohidrosis Sensation Disorders Cerebral Palsy Spasm Hemiplegia Meige Syndrome Deglutition Disorders Tremor Fissure in Ano Stroke Esophageal Achalasia Muscle Cramp Sweating, Gustatory Spinal Cord Injuries Pain Movement Disorders Urinary Bladder, Overactive Equinus Deformity Voice Disorders

Chemicals and Drugs20

Botulinum Toxins, Type A Neuromuscular Agents Botulinum Toxins Anti-Dyskinesia Agents Botulinum Antitoxin Muscle Relaxants, Central Receptors, Dopamine D5 Neurotoxins Shiga Toxin 2 Tetanus Toxin Parasympatholytics Shiga Toxin 1 Cholera Toxin T-2 Toxin Shiga Toxins Synaptosomal-Associated Protein 25 Enterotoxins Bacterial Toxins Toxins, Biological Antitoxins

Analytical, Diagnostic and Therapeutic Techniques and Equipment17

Injections, Intramuscular Cosmetic Techniques Injections Cryoanesthesia Treatment Outcome Pain Measurement Electromyography Deep Brain Stimulation Gait Severity of Illness Index Range of Motion, Articular Follow-Up Studies Double-Blind Method Prospective Studies Quality-Adjusted Life Years Lethal Dose 50 Magnetic Resonance Imaging

Psychiatry and Psychology1

Phenomena and Processes8

Skin Aging Therapeutic Equivalency Gait Range of Motion, Articular Dose-Response Relationship, Drug Lethal Dose 50 Posture Pain

Information Science2

Quality-Adjusted Life Years Handwriting

Health Care8

Treatment Outcome Severity of Illness Index Follow-Up Studies Double-Blind Method Prospective Studies Quality-Adjusted Life Years Patient Satisfaction Cost-Benefit Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Health Care

Botulinum Toxins, Type A Torticollis Neuromuscular Agents Botulinum Toxins Dystonia Anti-Dyskinesia Agents Muscle Spasticity Clostridium botulinum Dystonic Disorders Injections, Intramuscular Botulism Blepharospasm Botulinum Antitoxin Hyperhidrosis Sialorrhea Paraparesis, Spastic Cosmetic Techniques Hemifacial Spasm Dystonia Musculorum Deformans Skin Aging Muscle Relaxants, Central Neck Muscles Hypohidrosis Sensation Disorders Globus Pallidus Injections Cerebral Palsy Spasm Cryoanesthesia Treatment Outcome Receptors, Dopamine D5 Hemiplegia Upper Extremity Neurotoxins Meige Syndrome Shiga Toxin 2 Cervical Vertebrae Deglutition Disorders Sweat Glands Tremor Pain Measurement Electromyography Tetanus Toxin Basal Ganglia Fissure in Ano Therapeutic Equivalency Deep Brain Stimulation Clostridium botulinum type A Parasympatholytics Clostridium botulinum type E Stroke Gait Shiga Toxin 1 Facial Muscles Severity of Illness Index Cholera Toxin Range of Motion, Articular Follow-Up Studies Double-Blind Method Prospective Studies Esophageal Achalasia T-2 Toxin Quality-Adjusted Life Years Muscle Cramp Shiga Toxins Sweating, Gustatory Dose-Response Relationship, Drug Spinal Cord Injuries Lethal Dose 50 Synaptosomal-Associated Protein 25 Enterotoxins Handwriting Posture Neuromuscular Junction Pain Bacterial Toxins Patient Satisfaction Toxins, Biological Movement Disorders Antitoxins Oculomotor Muscles Urinary Bladder, Overactive Cost-Benefit Analysis Equinus Deformity Magnetic Resonance Imaging Voice Disorders Clostridium botulinum type B

No FAQ available that match "cervical dystonia receiving treatment with botulinum toxin type"